PerkinElmer Inc (PKI.N)
78.40USD
19 Jul 2018
-- (--)
$78.40
--
--
--
--
164,721
$84.42
$62.43
About
Overall
| Beta: | 0.88 |
| Market Cap(Mil.): | $8,511.10 |
| Shares Outstanding(Mil.): | 110.63 |
| Dividend: | 0.07 |
| Yield (%): | 0.36 |
Financials
| PKI.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 34.26 | 37.53 | 33.05 |
| EPS (TTM): | 2.29 | -- | -- |
| ROI: | 5.67 | 8.77 | 13.17 |
| ROE: | 10.64 | 12.58 | 15.10 |
UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street
April 30 Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.
PerkinElmer first-quarter profit beats Street view
April 30 Laboratory equipment maker PerkinElmer on Monday reported slightly higher-than-expected first-quarter profit and revenue and raised its full-year earnings forecast as sales grew in both of its business units.
BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer
* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:
BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics
* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS
BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering
* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING Source text: (https://bit.ly/2q3PNq6) Further company coverage:
BRIEF-RHS Enters Deal For Perkinelmer, Inc To Buy All Shares Of Co For $0.28 Per Share
* ENTERS SCHEME IMPLEMENTATION AGREEMENT FOR PERKINELMER, INC TO BUY ALL SHARES OF CO FOR $0.28 PER SHARE
BRIEF-Perkinelmer Reports Q4 GAAP Loss Per Share From Cont Ops of $0.35
* Q4 ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS $0.97
PerkinElmer profit, 2018 forecast top Wall Street estimates
Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
UPDATE 1-PerkinElmer profit, 2018 forecast top Wall Street estimates
Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
PerkinElmer profit, 2018 forecast top Wall Street estimates
Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
Competitors
| Price | Chg | |
|---|---|---|
| Thermo Fisher Scientific Inc. (TMO.N) | $216.08 | -- |
| Agilent Technologies Inc (A.N) | $64.15 | -- |
| Waters Corporation (WAT.N) | $197.64 | -- |
Estimates